covaxin

New Delhi: Bharat Biotech, which has a stockpile of more than 50 million doses of Covaxin ready to be distributed as required, is well-tolerated and immunogenic in the paediatric population in phase 2/3 studies, according to a study…

Hyderabad: The final analysis of Covaxin's efficacy from phase 3 clinical trials have been released. The overall efficacy of the COVID-19 is 77.8 per cent, said Bharat Biotech. Covaxin efficacy on Delta variant The vaccine was found to…

New Delhi: As the threat of a third wave of COVID-19 looms, India is eagerly awaiting a vaccine for children. Especially as some experts fear that children could be more affected by an almost ‘inevitable’ third wave. According to All India…

New Delhi: AstraZeneca joins other vaccines that are effective against the Delta variant. COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian variant), new data…

Can the same person be administered two different COVID-19 vaccines to the same person? That, too, in the space of five minutes? However bizarre it might sound, that is exactly what happened in Bihar. A 63-year-old woman was given both…

Hyderabad: The World Health Organization (WHO) is a step closer to granting an emergency use listing (EUL) to Covaxin after Bharat Biotech provided additional data on the vaccine sought by the world body. According to a document on the WHO…

New Delhi: The supply price of COVID-19 vaccine Covaxin to the Central government at Rs 150 per dose is not sustainable in the long run, Bharat Biotech said on Tuesday. The Centre’s supplying price is pushing the pricing structure for the…

New Delhi: Recruitment for the clinical trial of Covaxin among children aged 2-12 will begin at AIIMS Delhi on Tuesday. According to Dr Sanjay Rai, Professor at Centre for Community Medicine, AIIMS, the trial will first be held for age…

Mumbai/Hyderabad: COVID-19 vaccines — Covishield and Covaxin — could produce a high immune response in up to 95 per cent of recipients and prevent serious disease in those infected after inoculation, a ‘real-world’ study of the vaccinated…

Patna: Bharat Biotech has started paediatric trials of its COVID-19 vaccine Covaxin at the All India Institute of Medical Sciences (AIIMS) Patna. The Drugs Controller General of India last month approved clinical trials of Covaxin among…